Tocilizumab (Anti-IL6-Receptor) Therapy for Donor Specific Antibody (DSA+) Antibody Mediated Rejection (ABMR+) Resistant to IVIG + Rituximab Treatment Conference Paper

authors

publication date

  • 2014

presented at event